Press "Enter" to skip to content

New patent for Gilead Sciences drug VOSEVI

0
Copyright © DrugPatentWatch. Originally published at New patent for Gilead Sciences drug VOSEVI

Annual Drug Patent Expirations for VOSEVI
Annual Drug Patent Expirations for VOSEVI

Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

Drug patent litigation for VOSEVI.

This drug has two hundred and seventy-seven patent family members in forty-seven countries.

The generic ingredient in VOSEVI is sofosbuvir; velpatasvir; voxilaprevir. One supplier is listed for this compound. Additional details are available on the sofosbuvir; velpatasvir; voxilaprevir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Gilead Sciences drug VOSEVI
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions